The north-east corridor of South Asia has regions with high level of P. falciparum, high levels of pathogenesis, and high levels of drug failures. In complete contrast, southern regions of India still carry predominantly P. vivax. In these regions malaria presentations appear more benign. Interestingly, profiles of malaria cases in central India are changing rapidly thus providing an extraordinary opportunity to study the factors that may be driving the evolution of malaria. The most obvious explanation for higher levels of P. falciparum in central India is that specific parasite strains are moving from "source" sites (involving high levels of virulence) to new "sink" sites, which historically presented more benign P. vivax infections. Another, more intriguing explanation is that the "whole parasite" does not need to move;specific virulence traits, coded by specific genes, may propagate by recombination across regions. Local parasites that have acquired new virulence traits may compete more effectively against local P. vivax parasite populations. In order to investigate this, one general goal of Project 1 is to systematically and carefully define the population structures of P. falciparum and P. vivax in South Asia. A second general goal is to determine if detailed genotypic analysis of parasites allow us to correlate parasite genotypes to specific disease outcomes.
TO OVERALL APPLICATION: Project 1 will begin collecting samples in four sites across India: Mumbai, Goa, Wardha, and Ranchi. This epidemiology project is specifically designed to capture the history of parasite infection of individual patients and to share these parasites with other projects. Initial sampling at these sites will also serve to standardize data collection, distribution, and testing for all proiects in this grant. Following establishment ofthe initial field sites, the other projects will expand into other geographic regions throughout South Asia (India). Their deliberate stepwise expansion is necessary for high tech applications such as scaling whole genome analysis and phenotype screening techniques.
|Deng, Xiaoyi; Kokkonda, Sreekanth; El Mazouni, Farah et al. (2014) Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors. J Med Chem 57:5381-94|
|Rice, Benjamin L; Acosta, Mónica M; Pacheco, M Andreína et al. (2014) The origin and diversification of the merozoite surface protein 3 (msp3) multi-gene family in Plasmodium vivax and related parasites. Mol Phylogenet Evol 78:172-84|
|Turner, Louise; Lavstsen, Thomas; Berger, Sanne S et al. (2013) Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature 498:502-5|
|Herricks, Thurston; Avril, Marion; Janes, Joel et al. (2013) Clonal variants of Plasmodium falciparum exhibit a narrow range of rolling velocities to host receptor CD36 under dynamic flow conditions. Eukaryot Cell 12:1490-8|
|Guler, Jennifer L; Freeman, Daniel L; Ahyong, Vida et al. (2013) Asexual populations of the human malaria parasite, Plasmodium falciparum, use a two-step genomic strategy to acquire accurate, beneficial DNA amplifications. PLoS Pathog 9:e1003375|
|Kumar, Ashwani; Chery, Laura; Biswas, Chinmoy et al. (2012) Malaria in South Asia: prevalence and control. Acta Trop 121:246-55|
|Tutterrow, Yeung L; Avril, Marion; Singh, Kavita et al. (2012) High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission. Infect Immun 80:1479-90|
|Narayanasamy, Krishnamoorthy; Chery, Laura; Basu, Analabha et al. (2012) Malaria evolution in South Asia: knowledge for control and elimination. Acta Trop 121:256-66|
|Herricks, Thurston; Seydel, Karl B; Turner, George et al. (2011) A microfluidic system to study cytoadhesion of Plasmodium falciparum infected erythrocytes to primary brain microvascularendothelial cells. Lab Chip 11:2994-3000|
|Gujjar, Ramesh; El Mazouni, Farah; White, Karen L et al. (2011) Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice. J Med Chem 54:3935-49|